Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 65/100

Failure Rate

16.7%

1 terminated/withdrawn out of 6 trials

Success Rate

66.7%

-19.8% vs industry average

Late-Stage Pipeline

17%

1 trials in Phase 3/4

Results Transparency

0 of 2 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

N/A

4(80.0%)

Phase 3

1(20.0%)

5Total

N/A(4)

Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials

NCT06206616Recruiting

Liver Steatosis in Pediatric CD Patients

Role: collaborator

NCT06360653Not ApplicableRecruiting

a SIngle Center Study of Post-operative STEReotactic RAdiotherapY for Endometrial Cancer

Role: lead

NCT05019989Not ApplicableCompleted

Trial of Diet, Physical Activity and Breast Cancer Recurrences: the DIANA-5 Study

Role: collaborator

NCT04169659Not ApplicableUnknown

Kyphoplasty With Structured Titanium Spheres

Role: lead

NCT03849209Not ApplicableCompleted

Different Suction Techniques For Endoscopic Ultrasound-Guided Fine-Needle Biopsy In Pancreatic Solid Lesions

Role: lead

NCT02509273Phase 3Terminated

Efficacy, Safety and Pharmacokinetic Study of Intravenous Clonidine Versus Midazolam for Sedation in Paediatric Patients

Role: collaborator

All 6 trials loaded